-transparent.png){kind=logo}
Acyclovir sodium is the drug of choice for the treatment of herpes simplex encephalitis. We treated an immunocompetent patient with a ten-day course of intravenous acyclovir sodium at the recommended dosage of 10 mg/kg every eight hours for clinically apparent herpes simplex encephalitis. After marked improvement, his condition deteriorated four days after completing acyclovir therapy. A subsequent brain biopsy specimen disclosed acyclovir-sensitive herpes simplex virus type 1. A longer duration of acyclovir therapy (14 to 21 days) should be considered for treating herpes simplex encephalitis.
Related Publications
K E VanLandingham, and
H B Marsteller, and
G W Ross, and
F G Hayden
December 1983,
Australian and New Zealand journal of medicine,
K E VanLandingham, and
H B Marsteller, and
G W Ross, and
F G Hayden
September 1993,
European journal of pediatrics,
K E VanLandingham, and
H B Marsteller, and
G W Ross, and
F G Hayden
February 1988,
JAMA,
K E VanLandingham, and
H B Marsteller, and
G W Ross, and
F G Hayden
January 1996,
Infection,
K E VanLandingham, and
H B Marsteller, and
G W Ross, and
F G Hayden
January 1986,
The New England journal of medicine,
K E VanLandingham, and
H B Marsteller, and
G W Ross, and
F G Hayden
June 1996,
Annals of tropical paediatrics,
K E VanLandingham, and
H B Marsteller, and
G W Ross, and
F G Hayden
October 1987,
Medicina clinica,
K E VanLandingham, and
H B Marsteller, and
G W Ross, and
F G Hayden
June 2010,
Annals of neurology,
K E VanLandingham, and
H B Marsteller, and
G W Ross, and
F G Hayden
September 1995,
Journal of child neurology,
K E VanLandingham, and
H B Marsteller, and
G W Ross, and
F G Hayden
February 1987,
Neuropediatrics,
